PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES

PREVENTION OF COMPLICATIONS IN CASTRATE-REFRACTORY PROSTATE CANCER PATIENTS WITH BONE METASTASES

Abstract:Prostate cancer (PC) is one of the most urgent problems in modern oncourology. Every year the world is recording more than 900 thousands new cases of prostate cancer. For this reason, the diagnosis and treatment of this disease has recently been given more attention, both abroad and in the...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. M. Nushko, A. S. Kalpinskiy, A. D. Kaprin
Format:	Article
Language:	Russian
Published:	QUASAR, LLC 2015-10-01
Series:	Исследования и практика в медицине
Subjects:	bone metastasis osteoporosis prostate cancer bisphosphonate zoledronic acid resorba prevention
Online Access:	https://www.rpmj.ru/rpmj/article/view/87
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of bisphosphonate on bone microstructure, mechanical strength in osteoporotic rats by ovariectomy
by: Yuzhu Wang, et al.
Published: (2024-09-01)

GDF15 propeptide promotes bone metastasis of castration-resistant prostate cancer by augmenting the bone microenvironment
by: Gaku Yamamichi, et al.
Published: (2024-11-01)

Bone-Targeting Radionuclides in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review on Radium-223 Chloride (Alpharadin) in Combination with Other Therapies
by: Ali H. D. Alshehri
Published: (2024-10-01)

Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
by: P Madhuchandra, et al.
Published: (2024-01-01)

Bone manifestations in Snyder‐Robinson syndrome
by: Teri L. Koerner, et al.
Published: (2024-01-01)

Harnessing curcumin and nanotechnology for enhanced treatment of breast cancer bone metastasis
by: Shiva Shakori Poshteh, et al.
Published: (2024-11-01)

Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate Cancer
by: Colleen Mackenzie, et al.
Published: (2024-10-01)

Comprehensive evaluation of compound Kushen injection combined with zoledronic acid in treating bone metastasis cancer pain based on meta-analysis and decision tree model
by: Xi Zhao, et al.
Published: (2025-01-01)

Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01)

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia
by: Weilong Li, et al.
Published: (2024-11-01)

Comparative Analysis of Extracorporeal Shockwave Therapy, Bisphosphonate, and Wharton Jelly-Derived Mesenchymal Stem Cells in Preserving Bone and Cartilage Integrity and Modulating IL31, IL33, and BMP2 in the Cartilage of Ovariectomized Rat Model
by: Jai-Hong Cheng, et al.
Published: (2024-12-01)

Artificial intelligence and radiomics applied to prostate cancer bone metastasis imaging: A review
by: S. J. Pawan, et al.
Published: (2024-12-01)

Assessment of the Admission and Follow-up Characteristics of Children Diagnosed with Secondary Osteoporosis
by: Emine Kübra Şen, et al.
Published: (2024-12-01)

Prostate Cancer Bone Metastasis: Molecular Mechanisms of Tumor and Bone Microenvironment
by: Jiang H
Published: (2025-02-01)

Influence of Bisphosphonates on Alveolar Bone Loss around Osseointegrated Implants
by: Vivek, et al.
Published: (2024-12-01)

Diagnostic Accuracy of Serum Prostate Specific Antigen and Gleason Score in Determining the Presence of Skeletal Metastasis in Prostate Cancer Patients: a Pakistani Perspective
by: Taimoor Nasir, et al.
Published: (2023-04-01)

Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01)

MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model
by: Manta Morakotsriwan, et al.
Published: (2024-12-01)

Superiority of denosumab over bisphosphonates in preventing and treating glucocorticoid-induced osteoporosis: a systematic review and meta-analysis with GRADE quality assessment
by: Chiao-Ling Chen, et al.
Published: (2024-12-01)

Hyponatremia after intravenous zoledronic acid administration: A case report
by: Nafis Vural, et al.
Published: (2023-12-01)

Risk Factors for Acute Febrile Reaction after Zoledronic Acid Treatment for Primary Osteoporosis
by: WU Hongliang, et al.
Published: (2022-06-01)

Therapeutic potential of bisphosphonates - review of medical indications, mechanism of action, interactions and adverse effects
by: Agnieszka Mikosińska, et al.
Published: (2025-01-01)

Tibial Insufficiency Fracture with Characteristics of an Atypical Fracture: A Rare Case and Literature Review
by: Ju-Yeong Kim, et al.
Published: (2024-11-01)

Using DEXA to diagnose impending atypical femoral fracture in an asymptomatic patient on long term bisphosphonates: A case report of a missed opportunity for fracture prevention
by: Ashraf Amin Ariff, et al.
Published: (2024-11-01)

Diagnostic Ability of Quantitative Parameters of Whole-Body Bone SPECT/CT Using a Full-Ring 360° Cadmium-Zinc-Telluride Camera for Detecting Bone Metastasis in Patients with Prostate Cancer
by: Ik Dong Yoo, et al.
Published: (2024-12-01)

RADIUM-223. PLACE IN THE TREATMENT OF METASTATIC CASTRATION-REFRACTORY PROSTATE CANCER
by: A. A. Kostin, et al.
Published: (2017-12-01)

The effect of cold atmospheric plasma on viability of osteoblasts and expression of RANKL and OPG genes in medium with bisphosphonates
by: Zahra Rahati Ghuchani, et al.
Published: (2024-11-01)

Medication related osteonecrosis (MRONJ) in the management of CTIBL in breast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
by: Francesco Bertoldo, et al.
Published: (2025-02-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

The effect of denosumab vs. zoledronic acid in preventing skeletal-related events, including pain-related bone metastasis: a systematic review
by: I. Putu Eka Widyadharma, et al.
Published: (2024-10-01)

Health-related quality of life following bisphosphonate therapy in individuals with Paget’s disease of bone – A study from a teaching hospital in Southern India
by: Fibi K. Ninan, et al.
Published: (2025-01-01)

Amorphous calcium phosphate-coated surfaces as a model for bone microenvironment in prostate cancer
by: Rebeca San Martin, et al.
Published: (2025-02-01)

Sequential therapy with teriparatide following zoledronic acid in severe osteoporotic vertebral compression fracture: A case report
by: Xuanwei Wang, et al.
Published: (2024-12-01)

DIAGNOSTICS OF BONE METABOLISM DISORDERS IN ONCOLOGICAL DISEASES
by: O. I. Apolikhin, et al.
Published: (2016-01-01)

A Rare Metastasis of Prostate Cancer
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

On a data-driven mathematical model for prostate cancer bone metastasis
by: Zholaman Bektemessov, et al.
Published: (2024-12-01)

Comparative efficacy and safety of bisphosphonate therapy for bone loss in individuals after middle age: A systematic review and network meta-analysis
by: Qin Hu, et al.
Published: (2022-03-01)

Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy
by: Sihyeon Kim, et al.
Published: (2023-11-01)

Zoledronic Acid Inhibits Lipopolysaccharide‐Induced Osteoclastogenesis by Suppressing Macrophage NLRP3‐Mediated Autophagy Pathway
by: Yuting Cheng, et al.
Published: (2024-12-01)

Routine use of denosumab for prevention of skeletal-related events in patients with bone metastases from prostate carcinoma in Bulgaria: a prospective observational study
by: Antoaneta Tomova, et al.
Published: (2024-12-01)